Suppr超能文献

前瞻性验证 Dante Pazzanese 风险评分在非 ST 段抬高型急性冠状动脉综合征中的应用。

Prospective validation of the Dante Pazzanese risk score in non-ST-segment elevation acute coronary syndrome.

出版信息

Arq Bras Cardiol. 2013 Sep;101(3):197-204. doi: 10.5935/abc.20130163. Epub 2013 Aug 14.

Abstract

BACKGROUND

In non-ST-segment elevation acute coronary syndrome (ACS), the likelihood of adverse events should be estimated. Guidelines recommend risk stratification models for that purpose. The Dante Pazzanese risk score (DANTE score) is a simple risk stratification model composed with the following variables: age increase (0 to 9 points); history of diabetes mellitus (2 points) or stroke (4 points); no use of angiotensin-converting-enzyme inhibitor (1 point); creatinine elevation (0 to 10 points); combination of troponin elevation and ST-segment depression (0 to 4 points).

OBJECTIVE

To validate the DANTE score in patients with non-ST-segment elevation ACS.

METHODS

Prospective, observational study including 457 patients, from September 2009 to October 2010. The patients were grouped in risk categories according to the original model score as follows: very low; low; intermediate; and high. The predictive ability of the score was assessed by using C-statistics.

RESULTS

The sample comprised 291 (63.7%) men, the mean age being 62.1 years (SD=11.04). The event death or (re)infarction in 30 days was observed in 17 patients (3.7%). Progressive increase in the proportion of events was observed as the score increased: very low risk = 0.0%; low risk = 3.9%; intermediate risk = 10.9%; high risk = 60.0%; p < 0.0001. C-statistics was 0.87 (95% CI: 0.81-0.94; p < 0.0001).

CONCLUSION

DANTE score showed an excellent capacity to predict the specific events, and can be incorporated to the prognostic assessment of patients with non-ST-segment elevation ACS.

摘要

背景

在非 ST 段抬高型急性冠状动脉综合征(ACS)中,应估计不良事件的可能性。为此,指南推荐风险分层模型。但丁·帕萨泽风险评分(DANTE 评分)是一种简单的风险分层模型,由以下变量组成:年龄增加(0 至 9 分);糖尿病史(2 分)或中风(4 分);未使用血管紧张素转换酶抑制剂(1 分);肌酐升高(0 至 10 分);肌钙蛋白升高和 ST 段压低的组合(0 至 4 分)。

目的

验证 DANTE 评分在非 ST 段抬高型 ACS 患者中的有效性。

方法

前瞻性、观察性研究,纳入 2009 年 9 月至 2010 年 10 月的 457 例患者。根据原始模型评分将患者分为低危、中危和高危。通过 C 统计量评估评分的预测能力。

结果

样本包括 291 名(63.7%)男性,平均年龄为 62.1 岁(标准差=11.04)。30 天内观察到 17 例死亡或(再)梗死事件(3.7%)。随着评分的增加,观察到事件的比例逐渐增加:低危=0.0%;中危=3.9%;高危=10.9%;极高危=60.0%;p<0.0001。C 统计量为 0.87(95%置信区间:0.81-0.94;p<0.0001)。

结论

DANTE 评分对特定事件的预测能力较强,可纳入非 ST 段抬高型 ACS 患者的预后评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acc2/4032298/3699c4bf728a/abc-101-03-0197-g01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验